RI
ACET icon

RTW Investments’s Adicet Bio ACET Stock Holding History

RTW Investments’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-65,856
Closed -$1.27M – 69
2024
Q2 		$1.27M Sell
65,856
-192,558
-75% -$5.16M 0.02% 67
2024
Q1 		$9.72M Hold
258,414
– – 0.14% 54
2023
Q4 		$7.81M Sell
258,414
-6,678
-3% -$146K 0.12% 53
2023
Q3 		$5.81M Hold
265,092
– – 0.12% 55
2023
Q2 		$10.3M Hold
265,092
– – 0.2% 48
2023
Q1 		$24.4M Hold
265,092
– – 0.51% 32
2022
Q4 		$37.9M Hold
265,092
– – 0.77% 28
2022
Q3 		$60.3M Buy
265,092
+18,137
+7% +$4.6M 1.39% 24
2022
Q2 		$57.7M Buy
246,955
+60,112
+32% +$13.2M 1.49% 25
2022
Q1 		$59.7M Sell
186,843
-2,141
-1% -$492K 1.24% 30
2021
Q4 		$52.9M Buy
+188,984
New +$32.4M 0.77% 39

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

RTW Investments's ACET Position: Q3 2024 in Review

RTW Investments sold out of Adicet Bio (ACET) in Q3 2024, closing a stake of 65,856 shares — an estimated $1.27M sold.

RTW Investments first reported a position in ACET in Q4 2021 and held it in 11 quarters. The position peaked at $60.3M in Q3 2022. 64 funds tracked by Wall St. Rank hold ACET as of Q3 2024.

  • RTW Investments reported no remaining Adicet Bio position as of Q3 2024 after selling out during the quarter.
  • RTW Investments sold 65,856 Adicet Bio shares in Q3 2024, an estimated $1.27M.
  • RTW Investments first reported a position in Adicet Bio in Q4 2021 and held it in 11 quarters.
  • RTW Investments's Adicet Bio position peaked at $60.3M in Q3 2022.
  • 64 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2024.

Based on RTW Investments's 13F filing for Q3 2024, filed 14 Nov 2024.